Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Argireline is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner49, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.
While Argireline works as acetyl hexapeptide-8 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2), a SNAP-25–mimetic peptide that competitively inhibits SNARE complex assembly, reducing acetylcholine release at neuromuscular junctions and attenuating facial muscle contraction4959, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.
Argireline
Not assigned in the current dataset.
Tirzepatide
Not assigned in the current dataset.
Argireline and Tirzepatide are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Argireline is more often discussed in the realm of Dermatology and aesthetics, whereas Tirzepatide is more often associated with the realm of Metabolic and endocrine and Cardiovascular health. They also influence different molecular systems, with Argireline tracking more closely to SNARE complex while Tirzepatide centers more on GLP-1 receptor. Argireline has a more synthetic design origin, while Tirzepatide is closer to synthetic analog background and their development context also differs, with Argireline cosmetic grade while Tirzepatide is approved. Argireline takes the form of a linear peptide, whereas Tirzepatide is closer to a peptide conjugate, Argireline carries acetylation features, while Tirzepatide instead reflects lipidation and d-amino acid substitution changes; while their sequence patterns also diverge, with Argireline showing protein-mimetic sequence features and Tirzepatide showing alpha-helical domain features.